Language selection

Search

Details for: XOLAIR

Company: NOVARTIS PHARMACEUTICALS CANADA INC

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02459787XOLAIROMALIZUMAB75 MG / 0.5 MLSOLUTIONSUBCUTANEOUS
02260565XOLAIROMALIZUMAB150 MG / VIALPOWDER FOR SOLUTIONSUBCUTANEOUS
02459795XOLAIROMALIZUMAB150 MG / MLSOLUTIONSUBCUTANEOUS
Search Reported Side Effects Report a Side Effect

Summary Reports

Regulatory Decision Summary
Regulatory Decision Summary
Regulatory Decision Summary

Consumer Information

The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.

Date modified: